Soluble CD83 Regulates Dendritic Cell-T Cell Immunological Synapse Formation by Disrupting Rab1a-Mediated F-Actin

Wei Lin1, Shuping Zhou1, Meng Feng1

  • 1Institute of Basic Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Science, Jinan, China.

Insights

Soluble CD83 (sCD83) inhibits T cell activation by disrupting dendritic cell (DC) cytoskeletal rearrangements and DC-T cell contact. This pathway offers potential for new immunosuppressive therapies for autoimmune diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Autoimmune Disease Research

Background:

  • Dendritic cell-T cell (DC-T) interactions are crucial for T cell activation and immune responses.
  • Cytoskeletal regulation in DCs significantly influences DC-T cell contact and subsequent T cell activation.
  • Inhibitory factors affecting DC cytoskeletal regulation are not well understood.

Purpose of the Study:

  • To investigate the role of soluble CD83 (sCD83) in modulating DC-T cell interactions and T cell activation.
  • To elucidate the molecular mechanisms by which sCD83 affects DC cytoskeletal dynamics and synapse formation.
  • To evaluate the therapeutic potential of sCD83 in an animal model of autoimmune disease.

Main Methods:

  • Treatment of DCs with sCD83.
  • Assessment of DC-T cell contact, synapse formation, and T cell activation.
  • Analysis of F-actin rearrangements, MHC-II expression and localization, and Rab1a GTP-binding activity.
  • Evaluation of sCD83-treated DCs in a mouse model of experimental autoimmune uveitis.

Main Results:

  • sCD83 inhibited T cell activation by reducing DC-T cell contact and synapse formation.
  • sCD83 disrupted F-actin rearrangements in DCs, altering MHC-II expression/localization and synapse formation.
  • sCD83 decreased Rab1a GTP-binding activity, impacting LRRK2 colocalization and F-actin rearrangements.
  • sCD83-treated DCs ameliorated experimental autoimmune uveitis symptoms in mice.

Conclusions:

  • sCD83 negatively regulates DC-T cell contact and T cell activation through cytoskeletal disruption.
  • A novel signaling pathway involving sCD83, Rab1a, LRRK2, and F-actin impacts DC function.
  • sCD83 demonstrates therapeutic potential for treating autoimmune diseases like uveitis.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.8K